摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(E)-4-[(2-methoxycarbonyl-5-thiophen-2-ylthiophen-3-yl)amino]-4-oxobut-2-enoic acid

中文名称
——
中文别名
——
英文名称
(E)-4-[(2-methoxycarbonyl-5-thiophen-2-ylthiophen-3-yl)amino]-4-oxobut-2-enoic acid
英文别名
——
(E)-4-[(2-methoxycarbonyl-5-thiophen-2-ylthiophen-3-yl)amino]-4-oxobut-2-enoic acid化学式
CAS
——
化学式
C14H11NO5S2
mdl
——
分子量
337.4
InChiKey
GJODSFZNKNHKML-SNAWJCMRSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.7
  • 重原子数:
    22
  • 可旋转键数:
    6
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.07
  • 拓扑面积:
    149
  • 氢给体数:
    2
  • 氢受体数:
    7

文献信息

  • TARGETING LIPID METABOLISM AND FREE FATTY ACID (FFA) OXIDATION TO TREAT DISEASES MEDIATED BY RESIDENT MEMORY T CELLS (TRM)
    申请人:The Brigham & Women's Hospital, Inc.
    公开号:EP3755322A1
    公开(公告)日:2020-12-30
  • COMPOSITIONS AND METHODS FOR TREATING AND/OR PREVENTING CANCER BY INHIBITING FATTY ACID BINDING PROTEINS
    申请人:Lengyel Ernst
    公开号:US20120289570A1
    公开(公告)日:2012-11-15
    The present invention concerns methods and compositions for the inhibition or reduction of the primary tumor and metastasis by inhibition of fatty acid binding proteins.
  • Compositions and Methods for Treating and/or Preventing Cancer by Inhibiting Fatty Acid Binding Proteins
    申请人:The University of Chicago
    公开号:US20140363522A1
    公开(公告)日:2014-12-11
    The present invention concerns methods and compositions for the inhibition or reduction of the primary tumor and metastasis by inhibition of fatty acid binding proteins.
  • Targeting Lipid Metabolism and Free Fatty Acid (FFA) Oxidation to Treat Diseases Mediated by Resident Memory T Cells (TRM)
    申请人:The Brigham and Women's Hospital, Inc.
    公开号:US20200375965A1
    公开(公告)日:2020-12-03
    Methods for treating, or reducing risk of development or progression of, a tissue-resident memory T cells (TRM)-mediated disease, comprising administering a therapeutically effective amount of one or more inhibitors of exogenous lipid and free fatty acid uptake or of mitochondrial beta oxidation of internalized exogenous FFA (e.g., inhibitors of CD36 and/or FABP antagonists, e.g., inhibitors of FABP4 and/or FABP5, and/or CPT1) to a subject in need thereof.
  • US8748470B2
    申请人:——
    公开号:US8748470B2
    公开(公告)日:2014-06-10
查看更多

同类化合物

试剂2,2'-Thieno[3,2-b]thiophene-2,5-diylbis-3-thiophenecarboxylicacid 苯并[b]噻吩,3-(2-噻嗯基)- 甲基[2,3'-联噻吩]-5-羧酸甲酯 牛蒡子醇 B 十四氟-Alpha-六噻吩 三丁基(5''-己基-[2,2':5',2''-三联噻吩]-5-基)锡 α-四联噻吩 α-六噻吩 α-五联噻吩 α-七噻吩 α,ω-二己基四噻吩 5,5′-双(3-己基-2-噻吩基)-2,2′-联噻吩 α,ω-二己基六联噻吩 Α-八噻吩 alpha-三联噻吩甲醇 alpha-三联噻吩 [3,3-Bi噻吩]-2,2-二羧醛 [2,2’]-双噻吩-5,5‘-二甲醛 [2,2':5',2''-三联噻吩]-5,5''-二基双[三甲基硅烷] [2,2'-联噻吩]-5-甲醇,5'-(1-丙炔-1-基)- [2,2'-联噻吩]-5-甲酸甲酯 [2,2'-联噻吩]-5-乙酸,a-羟基-5'-(1-炔丙基)-(9CI) C-[2,2-二硫代苯-5-基甲基]胺 5’-己基-2,2’-联噻吩-5-硼酸频哪醇酯 5-辛基-1,3-二(噻吩-2-基)-4H-噻吩并[3,4-c]吡咯-4,6(5H)-二酮 5-苯基-2,2'-联噻吩 5-溴5'-辛基-2,2'-联噻吩 5-溴-5′-己基-2,2′-联噻吩 5-溴-5'-甲酰基-2,2':5'2'-三噻吩 5-溴-3,3'-二己基-2,2'-联噻吩 5-溴-3'-癸基-2,2':5',2''-三联噻吩 5-溴-2,2-双噻吩 5-溴-2,2'-联噻吩-5'-甲醛 5-氯-5'-苯基-2,2'-联噻吩 5-氯-2,2'-联噻吩 5-正辛基-2,2'-并噻吩 5-己基-5'-乙烯基-2,2'-联噻吩 5-己基-2,2-二噻吩 5-全氟己基-5'-溴-2,2'-二噻吩 5-全氟己基-2,2′-联噻吩 5-乙酰基-2,2-噻吩基 5-乙氧基-2,2'-联噻吩 5-丙酰基-2,2-二噻吩 5-{[[2,2'-联噻吩]-5-基}噻吩-2-腈 5-[5-(5-己基噻吩-2-基)噻吩-2-基]噻吩-2-羧酸 5-(羟甲基)-[2,2]-联噻吩 5-(噻吩-2-基)噻吩-2-甲腈 5-(5-甲酰基-3-己基噻吩-2-基)-4-己基噻吩-2-甲醛 5-(5-甲基噻吩-2-基)噻吩-2-甲醛 5-(5-噻吩-2-基噻吩-2-基)噻吩-2-羧酸 5-(5-乙炔基噻吩-2-基)噻吩-2-甲醛